| Product Code: ETC7174348 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji continued to see a significant influx of drug-device combination products imports, with key exporting countries including Australia, New Zealand, India, Bangladesh, and the USA. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period of 2020-2024 remained strong at 6.89%. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, suggesting a competitive landscape dominated by a few major players. Fiji`s reliance on these top exporting countries highlights the importance of maintaining strong trade relationships for the supply of essential healthcare products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Drug-Device Combination Products Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Fiji Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Fiji Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Fiji Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Fiji Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Fiji Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Fiji Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Fiji |
4.2.2 Technological advancements in drug-device combination products |
4.2.3 Growing demand for minimally invasive treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-device combination products |
4.3.2 High costs associated with development and manufacturing of these products |
4.3.3 Limited awareness and adoption of such products in the market |
5 Fiji Drug-Device Combination Products Market Trends |
6 Fiji Drug-Device Combination Products Market, By Types |
6.1 Fiji Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Fiji Drug-Device Combination Products Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Fiji Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022 - 2032F |
6.1.4 Fiji Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022 - 2032F |
6.1.5 Fiji Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022 - 2032F |
6.1.6 Fiji Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022 - 2032F |
6.1.7 Fiji Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022 - 2032F |
6.1.8 Fiji Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022 - 2032F |
6.1.9 Fiji Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.1.10 Fiji Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Fiji Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Fiji Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022 - 2032F |
6.2.3 Fiji Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.2.4 Fiji Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022 - 2032F |
6.2.5 Fiji Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022 - 2032F |
6.2.6 Fiji Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022 - 2032F |
6.2.7 Fiji Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Fiji Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Fiji Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022 - 2032F |
6.3.3 Fiji Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022 - 2032F |
6.3.4 Fiji Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022 - 2032F |
6.3.5 Fiji Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
7 Fiji Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Fiji Drug-Device Combination Products Market Export to Major Countries |
7.2 Fiji Drug-Device Combination Products Market Imports from Major Countries |
8 Fiji Drug-Device Combination Products Market Key Performance Indicators |
8.1 Rate of adoption of drug-device combination products by healthcare providers in Fiji |
8.2 Number of clinical trials and research studies conducted on these products |
8.3 Patient satisfaction and outcomes data related to the use of drug-device combination products |
9 Fiji Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Fiji Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Fiji Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Fiji Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Fiji Drug-Device Combination Products Market - Competitive Landscape |
10.1 Fiji Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Fiji Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here